To The Moon

$DexCom(DXCM)$

$DexCom, Inc.(DXCM) +0.38%: Glucose Monitor Leader Consolidates Near 52-Week High, $91.96 Breakout in Sight 📈

Latest Close Data: DXCM closed at $90.22 on Aug 21, up +0.38%, just 1.89% below its 52-week high of $91.96. After-hours trading held at $90.22, signaling stability.

Core Market Drivers: Dexcom's Q2 earnings beat on both EPS ($0.70 vs $0.61 est.) and revenue ($13.08B vs $12.90B est.), driven by strong continuous glucose monitor demand. The company raised full-year revenue guidance to $5.18–$5.25B, reinforcing bullish sentiment. Sector-wide medtech strength is providing additional tailwinds.

Technical Analysis: Volume ratio at 1.05 shows normal participation. MACD remains positive with DIF at 4.18 and DEA at 4.00, but histogram is contracting (0.36), suggesting momentum is cooling. RSI(6) at 67.99 and RSI(12) at 67.49 indicate bullish but not yet overbought conditions. KDJ shows K=78.5, D=81.1, J=73.3—still elevated but rolling over slightly.

Key Price Levels:

• Primary Support: $88.70 (recent consolidation floor)

• Strong Resistance: $91.96 (52-week high)

• Immediate Pivot: $89.90 (yesterday's close, now acting as intraday anchor)

Valuation Perspective: P/E TTM at 35.57 is below the historical average of 47.15, while Forward PE of 33.70 sits near the lower end of its 28.09–66.22 range. P/S ratio at 6.85 remains reasonable for high-growth medtech. ROE of 38.49% underscores strong profitability.

Analyst Targets: 25 analysts cover DXCM with average target of $93.88 (range $75–$115). Ratings: 13 Strong Buy, 13 Buy, 4 Hold—no sell ratings, confirming institutional conviction.

Weekly Outlook: Expect consolidation between $88.70 and $91.96. A breakout above $91.96 opens path to $95–$97; failure to hold $88.70 could trigger retest of $85 support. RSI cooling from overbought suggests healthy digestion before next leg higher.

⚠️ Risk Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.

🎯$DexCom, Inc.(DXCM) Options Strategy: Bull Call Spread

• Underlying: DXCM (DexCom, Inc.)

• View: Cautiously bullish — consolidation near 52-week high with momentum cooling but strong fundamentals and analyst conviction

• Strategy Type: Debit spread / directional long with defined risk

• Option Contract Portfolio:

  • Buy 1x DXCM 2026-08-28 $90 Call @ $2.275 (mid)

  • Sell 1x DXCM 2026-08-28 $95 Call @ $0.75 (mid)

• Max Gain & Loss:

  • Max Gain: $3.525 per spread (width $5 – net debit $1.475) = $352.50

  • Max Loss: Net debit of $147.50 per spread

• Initial Cost/Credit: Net Debit = $1.475 (mid: $2.275 – $0.75)

🐯🪙 Share your choice and reasoning in the comments — thoughtful views may receive Tiger Coins!

Good allocation isn’t just about investing — it’s also about keeping everyday life organised.

Just like a well-balanced portfolio, the right organisation can make business trips, travel and workouts a little easier. The new Tiger Toiletry Bag features a dual-layer dry & wet separation design with plenty of space to keep your essentials neatly organised, wherever you go.

Redeem the new Tiger Toiletry Bag now in Tiger Coin Mall. https://laohu8.com/J/redeemGift?goodID=100538&type=delivery